Recent Trends in Molecular Image-Guided Theranostic and Personalized Medicine
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 15890
Special Issue Editors
Interests: data science; machine learning; data structures and algorithms; systems engineering; neural networks; data mining; project management; tensor flow; predictive modelling; artificial intelligence; hadoop; apache spark; software development; empirical researchbig data
Special Issues, Collections and Topics in MDPI journals
Interests: computational intellgence; neural networks; image processing; expert systems
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The sudden increase in the market for molecular imaging science enhances the opportunities to develop new molecular imaging agents for diagnosis and therapy. New clinical indications using the proteomic or genomic expression in oncology, cardiology, and neurology also offer a stimulus. This promotes the growth of procedure volume and sales of clinic imaging agents and the development of new radiopharmaceuticals. The growing use of molecular imaging is also helping to control and monitor dosage for increased safety and effectiveness. For instance, molecular imaging in oncology has been focused on identifying tumor-specific markers and applying these markers for the evaluation of patient response to radiation therapy, chemotherapy, or chemo/radiotherapy. Therefore, molecular imaging technologies play a significant role in providing personalized therapy for patients. The opportunity to use image-guiding to select a patient for personalized therapy is truly the focus. The imaging findings could be integrated with metabolomics. In addition, the theranostic concept is equally important in the personalized therapy of diseases. The effort in image-guided cell therapy theranostic approaches in parallel with instrumentation development would be more accurate in evaluating patient response to treatment. This Special Issue will provide new molecular imaging agents and instrumentation development trends. This Special Issue will become the scientific tool for moving a concept from bench work to clinic product development. This Special Issue will be interesting to translational research scientists and support staff, such as clinicians, molecular biologists, imaging scientists, pharmaceutical developers, physicists, fellows, and staff. Both academic and clinical scientists are invited to submit their manuscripts.
Potential topics include, but are not limited to: The image-guided theranostic approach of diseases. Advances in bioimaging applications in preclinical drug discovery. Advances in imaging instrumentation development. Hybrid imaging modalities in disease management. Theranostic agents development. Imaging technology in drug development. Validation of imaging agents on new molecular targets. Personalized drug development from molecular imaging. Link metabolomics and imaging molecular pathways. Treatment delivery using big radiomics analysis. Patient follow-up using big deep analysis. Patient diagnosis, assessment, and consultation in big data. Computer-aided detection and diagnosis. Treatment simulation using computer vision. Image registration/fusion. Image segmentation/auto-contouring.
Dr. Muhammad Fazal Ijaz
Prof. Dr. Marcin Woźniak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- image-guided theranostic approach of diseases
- advances in bioimaging applications in preclinical drug discovery
- PET/CT and SPECT/CT in disease management
- radiation dosimetric determination for radiotheranostic agents
- imaging technology in drug development
- validation of imaging agents on new molecular targets
- personalized drug development from molecular imaging
- nonradioactive molecular imaging probes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.